about
Long unidirectional barbed suturing technique with extracorporeal traction in laparoscopic myomectomy.Evaluation of the usefulness of the MRI jelly method for diagnosing complete cul-de-sac obliteration.Total Laparoscopic Resection Surgery for a Cervical Carcinoma that Recurred in the Pelvic Sidewall After Radical Hysterectomy and Adjuvant Concurrent Chemoradiotherapy.Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera.Effect of an 8K ultra-high-definition television system in a case of laparoscopic gynecologic surgery.Single-site in-bag morcellation achieved via direct puncture of the pneumoperitoneum cap, a cordless electric morcellator, and a 5-mm flexible scope.Resection of the inferior pubic ramus to completely remove locally advance adenoid cystic carcinoma of Bartholin's gland.Oral leukoplakia, a precancerous lesion of squamous cell carcinoma, in patients with long-term pegylated liposomal doxorubicin treatment.Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.Unexpected result of minimally invasive surgery for cervical cancer.En Bloc Resection of an Aggressive Angiomyxoma by a Novel Combination Laparoscopic and Open Perineal ApproachLaparoscopic laterally extended endopelvic resection (LEER) for cervical carcinoma recurring at the pelvic sidewall after concurrent chemoradiotherapy: Our experience in three casesClinical management of the status of atypical endometrial cells using the descriptive reporting format for endometrial cytologyFeasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancerLaparoscopic Anterior Pelvic Exenteration with Super Radical Parametrectomy for a Recurrent Low-Grade Endometrial Sarcoma That is Resistant to Hormone Therapy and ChemotherapyComparison of the Technical Feasibility and Safety of Three Contained Morcellation Techniques: A Pilot Study in an Animal ModelAdjuvant treatment of endometrial cancer today
P50
Q30596779-9939B3DA-BCDC-4377-B03D-D178221BB253Q37725484-DAE4CD47-6B96-4587-99F6-458FF0B50AE5Q39392293-883DD89B-C5F5-4840-87CB-1D2821E28E1BQ39450324-CDA3C956-ADCE-4297-884C-B94AF1C76A23Q43280598-DF2BE9E5-0A97-42F0-949D-66E730D9C3B1Q47817398-2BEDCA41-0001-48A0-A680-A89F47723E10Q47887065-CB66D007-9D8C-4C78-9CA7-F84DFEE2ADDDQ50003156-1501DD06-8726-4F66-8EC4-BDA3E9E610ACQ50604804-5390961F-FE5D-449A-8FD2-7F1B9660F493Q55396010-45F63022-FFD1-4064-804B-463BA420DB81Q56526115-35962575-D759-4E58-9CDB-463594F8821FQ56551445-75CD88AE-8F90-4DE5-BF81-743291BFFCC3Q57054288-DC6385B6-C4A1-46D1-90C2-2F59A5E02B92Q64057531-0998A790-5115-4850-A136-6031578CDCE1Q88283800-105CB540-4832-4050-8524-E86975312FF6Q90615769-39766545-BF77-448F-8329-DE458C2E09F3Q95939513-ABF1F0C1-ABEF-499A-8131-B044EBC8E52D
P50
description
researcher ORCID ID = 0000-0003-0481-9892
@en
wetenschapper
@nl
name
Youichi Aoki
@ast
Youichi Aoki
@en
Youichi Aoki
@es
Youichi Aoki
@nl
type
label
Youichi Aoki
@ast
Youichi Aoki
@en
Youichi Aoki
@es
Youichi Aoki
@nl
prefLabel
Youichi Aoki
@ast
Youichi Aoki
@en
Youichi Aoki
@es
Youichi Aoki
@nl
P1153
55413786400
P31
P496
0000-0003-0481-9892